Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This is a single-center trial in subjects with pancreatic cancer and other advanced solid
tumors. It is an open-label, single arm dose escalation Phase IB trial with subjects accrued
in a 3 subject dose escalation cohort. Subjects with treated advanced solid tumors, and
showing disease progression on established standard therapy, will be enrolled in this trial.